Genetics

March 16, 2023 Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast. Read More ›
March 10, 2023 Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics Read More ›
January 18, 2018 Alnylam Co-Founds UK Biobank Exome Sequencing Consortium (UKB-ESC) Alnylam and partners announced an agreement with the UK Biobank to form the UK Biobank Exome Sequencing Consortium (UKB-ESC), to sequence all 500,000 exomes... Read More ›
Subscribe to Genetics

FOLLOW US

Visit our social channels to learn more about the innovative work we are doing at Alnylam.

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site